Your browser doesn't support javascript.
loading
Kasugamycin potentiates rifampicin and limits emergence of resistance in Mycobacterium tuberculosis by specifically decreasing mycobacterial mistranslation.
Chaudhuri, Swarnava; Li, Liping; Zimmerman, Matthew; Chen, Yuemeng; Chen, Yu-Xiang; Toosky, Melody N; Gardner, Michelle; Pan, Miaomiao; Li, Yang-Yang; Kawaji, Qingwen; Zhu, Jun-Hao; Su, Hong-Wei; Martinot, Amanda J; Rubin, Eric J; Dartois, Veronique Anne; Javid, Babak.
Afiliação
  • Chaudhuri S; Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
  • Li L; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, United States.
  • Zimmerman M; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, United States.
  • Chen Y; Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
  • Chen YX; Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
  • Toosky MN; Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
  • Gardner M; Department of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, United States.
  • Pan M; Department of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, United States.
  • Li YY; Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
  • Kawaji Q; Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
  • Zhu JH; Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
  • Su HW; Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
  • Martinot AJ; Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
  • Rubin EJ; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States.
  • Dartois VA; Department of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, United States.
  • Javid B; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, United States.
Elife ; 72018 08 28.
Article em En | MEDLINE | ID: mdl-30152756
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Biossíntese de Proteínas / Farmacorresistência Bacteriana / Aminoglicosídeos / Mycobacterium tuberculosis Limite: Animals Idioma: En Revista: Elife Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Biossíntese de Proteínas / Farmacorresistência Bacteriana / Aminoglicosídeos / Mycobacterium tuberculosis Limite: Animals Idioma: En Revista: Elife Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China